Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety-Reference-Cited by-同舟云学术

Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety

Published:2016-06 Issue:6 Volume:27 Page:1074-1081
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Luo H.Y.,Li Y.H.,Wang W.,Wang Z.Q.,Yuan X.,Ma D.,Wang F.H.,Zhang D.S.,Lin D.R.,Lin Y.C.,Jia J.,Hu X.H.,Peng J.W.,Xu R.H.

Funder

National High Technology Research and Development Program of China

National Natural Science Foundation of China

Science and Technology Program of Guangzhou

Science and Technology Department of Guangdong Province, China

Natural Science Foundation of Guangdong Province, China

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/6/1074/16701465/mdw101.pdf

Reference24 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Optimum chemotherapy for metastatic colorectal cancer;Bendell;Lancet,2006

3. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004

4. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

5. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases;Frontiers in Pharmacology;2024-07-26

2. A two-stage maintenance trial of cetuximab-based treatment in RAS and BRAF wild-type unresectable metastatic colorectal cancer: a retrospective real-world study;Frontiers in Oncology;2024-07-23

3. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial;Signal Transduction and Targeted Therapy;2024-04-03

4. Long‐term outcomes of metastasis‐directed stereotactic body radiation therapy in metastatic nasopharyngeal carcinoma;Cancer Medicine;2023-12-26

5. Organ-specific Tumor Response to Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma: A Multicenter Retrospective Study;Anticancer Research;2023-11-29